NM_000400.4(ERCC2):c.1891C>T (p.Arg631Cys) AND Xeroderma pigmentosum, group D
- Germline classification:
- Uncertain significance (1 submission)
- Last evaluated:
- Apr 28, 2017
- Review status:
- Somatic classification
of clinical impact: - None
- Review status:
- Somatic classification
of oncogenicity: - None
- Review status:
- Record status:
- current
- Accession:
- RCV001129002.4
Allele description [Variation Report for NM_000400.4(ERCC2):c.1891C>T (p.Arg631Cys)]
NM_000400.4(ERCC2):c.1891C>T (p.Arg631Cys)
Condition(s)
- Name:
- Xeroderma pigmentosum, group D (XPD)
- Synonyms:
- XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP D; XERODERMA PIGMENTOSUM IV; XP, GROUP D; See all synonyms [MedGen]
- Identifiers:
- MONDO: MONDO:0010212; MedGen: C0268138; OMIM: 278730
-
DETAILED OUTCOME DATA - Brivaracetam (Brivlera)
DETAILED OUTCOME DATA - Brivaracetam (Brivlera)
-
PA-X protein [Influenza A virus]
PA-X protein [Influenza A virus]gi|1386678732|gb|AWH12393.1|Protein
-
RESULTS - Brivaracetam (Brivlera)
RESULTS - Brivaracetam (Brivlera)
-
20p110 - Chromosomal Variation in Man
20p110 - Chromosomal Variation in Man
Your browsing activity is empty.
Activity recording is turned off.
See more...Assertion and evidence details
Last Updated: Sep 29, 2024